Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Nexteer Showcases Motion-by-Wire Innovations & Shares Insights on Software-Defined Vehicles at MOVE America
Steer-by-Wire, Rear-Wheel Steering, Brake-by-Wire, Software & More in Detroit September 24-25 DETROIT,…
Huawei Launches Xinghe AI Fabric 2.0, Empowering Enterprises to Create Always-on Data Center Networks with Full Computing Power
SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- At HUAWEI CONNECT 2025's inaugural Data…
Herbalife India Honored with ‘Sustainable Supply Chain Award’ at BIGBOX India 2025
BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- Herbalife India, a premier health…
Scientists Discuss the Recent CancerVax Breakthrough
The Company's scientific team describes how they successfully disguised cancer cells and…
Radware Schedules Conference Call for Its Second Quarter 2025 Earnings
TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR),…
UnitedHealth Group Announces Earnings Release Date
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its second quarter 2025 financial…
